Population
Patients with primary hypertriglyceridemia
Design
Review
Authors
Loading...
LpL-targeted therapies for hypertriglyceridemia merit prospective trials; should not yet change practice.
This review highlights the importance of lipoprotein lipase in triglyceride metabolism and outlines emerging therapies targeting this pathway for hypertriglyceridemia.
David Alpers (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: